Finance

Lists
Why is TECN up 3.17%?
Dive Deeper
TECN:SWX
Tecan Group AG
CHF 247.00
+3.17%
(+7.60) 1D
Oct 14, 5:31:30 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for TECN...
Open
CHF 239.80
High
CHF 247.60
Low
CHF 239.40
Mkt. cap
3.17B
Avg. vol.
74.77K
Volume
67.99K
Dividend
1.21%
Quarterly dividend
CHF 0.75
Ex-dividend date
Apr 17, 2026
52-wk high
CHF 256.80
52-wk low
CHF 110.60
EPS
-CHF 9.20
Shares outstanding
12.83M
No. of employees
3K
Open
CHF 239.80
High
CHF 247.60
Low
CHF 239.40
Mkt. cap
3.17B
Avg. vol.
74.77K
Volume
67.99K
Dividend
1.21%
Quarterly dividend
CHF 0.75
Ex-dividend date
Apr 17, 2026
52-wk high
CHF 256.80
52-wk low
CHF 110.60
EPS
-CHF 9.20
Shares outstanding
12.83M
No. of employees
3K
News stories
From web sources and news partners
Profile
Tecan Group Ltd. is a Swiss company providing laboratory instruments and solutions in biopharmaceuticals, forensics, clinical diagnostics and medical technology for pharmaceutical and biotechnology companies, university research departments, diagnostic laboratories and clinics. The company specializes in laboratory automation. As an original equipment manufacturer, it develops and manufactures OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland, in 1980, the company has over 3,500 employees, owns production and research and development sites in North America, Europe and APAC and maintains a sales and service network in 52 countries. In 2021, Tecan generated sales of CHF 946 million. Registered shares of Tecan Group are traded on the SIX Swiss Exchange. Wikipedia
About Tecan Group AG
CEO-
Employees3K
Founded1980
HeadquartersMännedorf, Zurich, Switzerland
SectorHealth care
Websitetecan.com
Previous reports
Loading Previous Earnings...
Revenue
Net income
All values in CHF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
221.50M
221.50M
213.76M
213.76M
Cost of goods sold
145.72M
145.72M
141.29M
141.29M
Cost of revenue
145.72M
145.72M
141.29M
141.29M
Research and development expenses
15.77M
15.77M
16.12M
16.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48.44M
48.44M
47.13M
47.13M
Operating expense
64.86M
64.86M
62.12M
62.12M
Total operating expenses
210.58M
210.58M
203.42M
203.42M
Operating income
10.92M
10.92M
10.34M
10.34M
Other non operating income
-226.50K
-226.50K
-
-
EBT including unusual items
-62.19M
-62.19M
7.87M
7.87M
EBT excluding unusual items
9.47M
9.47M
9.32M
9.32M
Income tax expense
2.10M
2.10M
1.74M
1.74M
Effective tax rate
-3.37%
-3.37%
22.05%
22.05%
Other operating expenses
649.50K
649.50K
-1.12M
-1.12M
Net income
-64.29M
-64.29M
6.14M
6.14M
Net profit margin
-29.02%
-29.02%
2.87%
2.87%
Earnings per share
-
-
-
-
Interest and investment income
616.00K
616.00K
590.00K
590.00K
Interest expense
-664.00K
-664.00K
-648.50K
-648.50K
Net interest expenses
-48.00K
-48.00K
-58.50K
-58.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
16.31M
16.31M
21.72M
21.72M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps